{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:25:57Z","timestamp":1788024357790,"version":"build-2784847793"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54-CA232568"],"award-info":[{"award-number":["U54-CA232568"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA237562"],"award-info":[{"award-number":["R01-CA237562"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35-CA220500"],"award-info":[{"award-number":["R35-CA220500"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Motivation<\/jats:title>\n                    <jats:p>Cancer remains a leading cause of mortality globally. Recent improvements in survival have been facilitated by the development of targeted and less toxic immunotherapies, such as chimeric antigen receptor (CAR)-T cells and antibody-drug conjugates (ADCs). These therapies, effective in treating both pediatric and adult patients with solid and hematological malignancies, rely on the identification of cancer-specific surface protein targets. While technologies like RNA sequencing and proteomics exist to survey these targets, identifying optimal targets for immunotherapies remains a challenge in the field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>To address this challenge, we developed ImmunoTar, a novel computational tool designed to systematically prioritize candidate immunotherapeutic targets. ImmunoTar integrates user-provided RNA-sequencing or proteomics data with quantitative features from multiple public databases, selected based on predefined criteria, to generate a score representing the gene\u2019s suitability as an immunotherapeutic target. We validated ImmunoTar using three distinct cancer datasets, demonstrating its effectiveness in identifying both known and novel targets across various cancer phenotypes. By compiling diverse data into a unified platform, ImmunoTar enables comprehensive evaluation of surface proteins, streamlining target identification and empowering researchers to efficiently allocate resources, thereby accelerating the development of effective cancer immunotherapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Availability and implementation<\/jats:title>\n                    <jats:p>Code and data to run and test ImmunoTar are available at https:\/\/github.com\/sacanlab\/immunotar.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btaf060","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:19:12Z","timestamp":1738941552000},"source":"Crossref","is-referenced-by-count":6,"title":["ImmunoTar\u2014integrative prioritization of cell surface targets for cancer immunotherapy"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5350-3386","authenticated-orcid":false,"given":"Rawan","family":"Shraim","sequence":"first","affiliation":[{"name":"Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia , Philadelphia, PA 19104,","place":["United States"]},{"name":"School of Biomedical Engineering, Science and Health System, Drexel University , Philadelphia, PA 19104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Mooney","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, BC Cancer Research Institute , Vancouver, BC V5Z 0B4,","place":["Canada"]},{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer Research Institute , Vancouver, BC V5Z 4S6,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina L","family":"Conkrite","sequence":"additional","affiliation":[{"name":"Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia , Philadelphia, PA 19104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber K","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia , Philadelphia, PA 19104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8949-4374","authenticated-orcid":false,"given":"Gregg B","family":"Morin","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer Research Institute , Vancouver, BC V5Z 4S6,","place":["Canada"]},{"name":"Department of Medical Genetics, University of British Columbia , Vancouver, BC V6T 1Z4,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul H","family":"Sorensen","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, BC Cancer Research Institute , Vancouver, BC V5Z 0B4,","place":["Canada"]},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia , Vancouver, BC V6T 1Z4,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Maris","sequence":"additional","affiliation":[{"name":"Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia , Philadelphia, PA 19104,","place":["United States"]},{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104,","place":["United States"]},{"name":"Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7200-8939","authenticated-orcid":false,"given":"Sharon J","family":"Diskin","sequence":"additional","affiliation":[{"name":"Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia , Philadelphia, PA 19104,","place":["United States"]},{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104,","place":["United States"]},{"name":"Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Sacan","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Science and Health System, Drexel University , Philadelphia, PA 19104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"2025031307374170700_btaf060-B1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020515","article-title":"Finding the keys to the CAR: identifying novel target antigens for T cell redirection immunotherapies","volume":"21","author":"Abbott","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025031307374170700_btaf060-B2","article-title":"Genetic algorithms for feature selection in the classification of COVID-19 patients","volume":"11","author":"Aliani","year":"2024","journal-title":"Bioengineering (Basel)"},{"key":"2025031307374170700_btaf060-B3","doi-asserted-by":"crossref","first-page":"D115","DOI":"10.1093\/nar\/gkh131","article-title":"UniProt: the universal protein knowledgebase","volume":"32","author":"Apweiler","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"2025031307374170700_btaf060-B4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The gene ontology consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"2025031307374170700_btaf060-B5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2011.11.032","article-title":"DLK1, Delta-like 1 homolog (drosophila), regulates tumor cell differentiation in vivo","volume":"318","author":"Begum","year":"2012","journal-title":"Cancer Lett"},{"key":"2025031307374170700_btaf060-B6","doi-asserted-by":"crossref","first-page":"bau012","DOI":"10.1093\/database\/bau012","article-title":"Compartments: unification and visualization of protein subcellular localization evidence","volume":"2014","author":"Binder","year":"2014","journal-title":"Database (Oxford)"},{"key":"2025031307374170700_btaf060-B7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ccell.2017.08.003","article-title":"Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma","volume":"32","author":"Bosse","year":"2017","journal-title":"Cancer Cell"},{"key":"2025031307374170700_btaf060-B8","doi-asserted-by":"crossref","first-page":"IJH39","DOI":"10.2217\/ijh-2021-0017","article-title":"Adhesion molecules in multiple myeloma oncogenesis and targeted therapy","volume":"11","author":"Bou Zerdan","year":"2022","journal-title":"Int J Hematol Oncol"},{"key":"2025031307374170700_btaf060-B9","volume-title":"Algorithms for Minimization Without Derivatives","author":"Brent","year":"2013"},{"key":"2025031307374170700_btaf060-B10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1338-5","article-title":"Gene expression across mammalian organ development","volume":"571","author":"Cardoso-Moreira","year":"2019","journal-title":"Nature"},{"key":"2025031307374170700_btaf060-B11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0965-9978(96)00051-8","article-title":"A new hybrid quadratic\/bisection algorithm for finding the zero of a nonlinear function without using derivatives","volume":"28","author":"Chandrupatla","year":"1997","journal-title":"Adv Eng Softw"},{"key":"2025031307374170700_btaf060-B12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/30.1.412","article-title":"TTD: therapeutic target database","volume":"30","author":"Chen","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2025031307374170700_btaf060-B13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41587-021-01038-8","article-title":"Identification of tumor antigens with immunopeptidomics","volume":"40","author":"Chong","year":"2022","journal-title":"Nat Biotechnol"},{"key":"2025031307374170700_btaf060-B14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"TEx the genotype-tissue expression (GTEx) project","volume":"45","author":"Consortium, G","year":"2013","journal-title":"Nat Genet"},{"key":"2025031307374170700_btaf060-B15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cels.2020.08.002","article-title":"Discriminatory power of combinatorial antigen recognition in cancer T cell therapies","volume":"11","author":"Dannenfelser","year":"2020","journal-title":"Cell Syst"},{"key":"2025031307374170700_btaf060-B16","doi-asserted-by":"crossref","first-page":"D1365","DOI":"10.1093\/nar\/gkaa882","article-title":"Project score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets","volume":"49","author":"Dwane","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2025031307374170700_btaf060-B17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-016-0378-7","article-title":"Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma","volume":"10","author":"Feng","year":"2017","journal-title":"J Hematol Oncol"},{"key":"2025031307374170700_btaf060-B18","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1038\/s41467-022-31810-6","article-title":"The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance","volume":"13","author":"Ferguson","year":"2022","journal-title":"Nat Commun"},{"key":"2025031307374170700_btaf060-B19","doi-asserted-by":"crossref","first-page":"e1700284","DOI":"10.1002\/pmic.201700284","article-title":"Translating immunopeptidomics to immunotherapy-decision-making for patient and personalized target selection","volume":"18","author":"Fritsche","year":"2018","journal-title":"Proteomics"},{"key":"2025031307374170700_btaf060-B20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2025031307374170700_btaf060-B21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djt007","article-title":"The clinical relevance of cancer cell lines","volume":"105","author":"Gillet","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2025031307374170700_btaf060-B22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ccell.2022.06.010","article-title":"Pan-cancer proteomic map of 949 human cell lines","volume":"40","author":"Goncalves","year":"2022","journal-title":"Cancer Cell"},{"key":"2025031307374170700_btaf060-B23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1158\/2159-8290.CD-23-0101","article-title":"Programming CAR T cell tumor recognition: tuned antigen sensing and logic gating","volume":"13","author":"Hamieh","year":"2023","journal-title":"Cancer Discov"},{"key":"2025031307374170700_btaf060-B24","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ccell.2024.10.003","article-title":"A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma","volume":"42","author":"Hamilton","year":"2024","journal-title":"Cancer Cell"},{"key":"2025031307374170700_btaf060-B25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168996","article-title":"CAR T-Cell therapy in hematological malignancies","volume":"22","author":"Haslauer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025031307374170700_btaf060-B26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41598-021-03748-0","article-title":"Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival","volume":"12","author":"Hathi","year":"2022","journal-title":"Sci Rep"},{"key":"2025031307374170700_btaf060-B27","doi-asserted-by":"publisher","author":"Hawkins","year":"2024","DOI":"10.1101\/2024.04.19.590243"},{"key":"2025031307374170700_btaf060-B28","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/mt.2013.185","article-title":"Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma","volume":"21","author":"Hegde","year":"2013","journal-title":"Mol Ther"},{"key":"2025031307374170700_btaf060-B29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-016-0334-6","article-title":"Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma","volume":"9","author":"Ho","year":"2016","journal-title":"J Hematol Oncol"},{"key":"2025031307374170700_btaf060-B30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41232-020-00113-y","article-title":"Integrins in multiple myeloma","volume":"40","author":"Hosen","year":"2020","journal-title":"Inflamm Regen"},{"key":"2025031307374170700_btaf060-B31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s43018-021-00282-w","article-title":"The cancer surfaceome atlas integrates genomic, functional and drug response data to identify actionable targets","volume":"2","author":"Hu","year":"2021","journal-title":"Nat Cancer"},{"key":"2025031307374170700_btaf060-B32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lfs.2012.10.021","article-title":"Cell adhesion molecule 1 is a new osteoblastic cell adhesion molecule and a diagnostic marker for osteosarcoma","volume":"92","author":"Inoue","year":"2013","journal-title":"Life Sci"},{"key":"2025031307374170700_btaf060-B33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cell.2020.08.036","article-title":"A quantitative proteome map of the human body","volume":"183","author":"Jiang","year":"2020","journal-title":"Cell"},{"key":"2025031307374170700_btaf060-B34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2018.07.001","article-title":"Comprehensive analysis of alternative splicing across tumors from 8,705 patients","volume":"34","author":"Kahles","year":"2018","journal-title":"Cancer Cell"},{"key":"2025031307374170700_btaf060-B35","article-title":"a fully-human antibody specifically targeting a membrane-bound fragment of cadm1 potentiates the t cell-mediated death of human small-cell lung cancer cells","volume":"23","author":"Lee","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025031307374170700_btaf060-B36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","article-title":"Identifying and targeting human tumor antigens for T Cell-based immunotherapy of solid tumors","volume":"38","author":"Leko","year":"2020","journal-title":"Cancer Cell"},{"key":"2025031307374170700_btaf060-B37","doi-asserted-by":"crossref","first-page":"eade2886","DOI":"10.1126\/scitranslmed.ade2886","article-title":"Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy","volume":"16","author":"Li","year":"2024","journal-title":"Sci Transl Med"},{"key":"2025031307374170700_btaf060-B38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbrc.2018.12.169","article-title":"GDNF family receptor alpha 2 promotes neuroblastoma cell proliferation by interacting with PTEN","volume":"510","author":"Li","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"2025031307374170700_btaf060-B39","first-page":"1","article-title":"Checkpoint immunotherapy in pediatrics: here, gone, and back again","volume":"42","author":"Long","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2025031307374170700_btaf060-B40","first-page":"1022","article-title":"Surface and global proteome analyses identify ENPP1 and other surface proteins as actionable immunotherapeutic targets in Ewing sarcoma","author":"Mooney","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2025031307374170700_btaf060-B41","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature07261","article-title":"Identification of ALK as a major familial neuroblastoma predisposition gene","volume":"455","author":"Mosse","year":"2008","journal-title":"Nature"},{"key":"2025031307374170700_btaf060-B42","doi-asserted-by":"crossref","first-page":"e960","DOI":"10.7717\/peerj-cs.960","article-title":"High-dimensional normalized data profiles for testing derivative-free optimization algorithms","volume":"8","author":"Musafer","year":"2022","journal-title":"PeerJ Comput Sci"},{"key":"2025031307374170700_btaf060-B43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41408-020-0331-4","article-title":"Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment","volume":"10","author":"Nair-Gupta","year":"2020","journal-title":"Blood Cancer J"},{"key":"2025031307374170700_btaf060-B44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/comjnl\/7.4.308","article-title":"A simplex method for function minimization","volume":"7","author":"Nelder","year":"1965","journal-title":"Comput J"},{"key":"2025031307374170700_btaf060-B45","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1182\/blood-2010-06-292243","article-title":"Integrin beta7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion","volume":"117","author":"Neri","year":"2011","journal-title":"Blood"},{"key":"2025031307374170700_btaf060-B46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/030006059802600104","article-title":"Expression of beta 1 integrins (very late antigens-4 and -5) on myeloma cells and clinical correlates in patients with multiple myeloma","volume":"26","author":"Nishinarita","year":"1998","journal-title":"J Int Med Res"},{"key":"2025031307374170700_btaf060-B47","doi-asserted-by":"crossref","first-page":"e2221116120","DOI":"10.1073\/pnas.2221116120","article-title":"IRIS: discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing","volume":"120","author":"Pan","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025031307374170700_btaf060-B48","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1158\/2159-8290.CD-21-0124","article-title":"The promising evolution of targeted therapeutic strategies in cancer","volume":"11","author":"Peters","year":"2021","journal-title":"Cancer Discov"},{"key":"2025031307374170700_btaf060-B49","doi-asserted-by":"crossref","first-page":"927312","DOI":"10.3389\/fbinf.2022.927312","article-title":"A review of feature selection methods for machine learning-based disease risk prediction","volume":"2","author":"Pudjihartono","year":"2022","journal-title":"Front Bioinform"},{"key":"2025031307374170700_btaf060-B50","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3892\/ijo.2016.3625","article-title":"L1-CAM knock-down radiosensitizes neuroblastoma IMR-32 cells by simultaneously decreasing MycN, but increasing PTEN protein expression","volume":"49","author":"Rached","year":"2016","journal-title":"Int J Oncol"},{"key":"2025031307374170700_btaf060-B51","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41416-023-02208-y","article-title":"Genomic ALK alterations in primary and relapsed neuroblastoma","volume":"128","author":"Rosswog","year":"2023","journal-title":"Br J Cancer"},{"key":"2025031307374170700_btaf060-B52","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13148-023-01433-9","article-title":"Expression of integrin beta-7 is epigenetically enhanced in multiple myeloma subgroups with high-risk cytogenetics","volume":"15","author":"Roy Choudhury","year":"2023","journal-title":"Clin Epigenetics"},{"key":"2025031307374170700_btaf060-B53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v053.i04","article-title":"GA: a package for genetic algorithms in R","volume":"53","author":"Scrucca","year":"2013","journal-title":"J Stat Softw"},{"key":"2025031307374170700_btaf060-B54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.21037\/atm.2019.05.58","article-title":"Immunotherapy and targeted therapy-the new roadmap in cancer treatment","volume":"7","author":"Shahid","year":"2019","journal-title":"Ann Transl Med"},{"key":"2025031307374170700_btaf060-B55","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1038\/s41467-024-47649-y","article-title":"Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression","volume":"15","author":"Shaw","year":"2024","journal-title":"Nat Commun"},{"key":"2025031307374170700_btaf060-B56","doi-asserted-by":"crossref","first-page":"D1097","DOI":"10.1093\/nar\/gkad831","article-title":"ADCdb: the database of antibody-drug conjugates","volume":"52","author":"Shen","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2025031307374170700_btaf060-B57","doi-asserted-by":"crossref","first-page":"e202100091","DOI":"10.1002\/cmtd.202100091","article-title":"Comparison of derivative-free algorithms for their applicability in self-optimization of chemical processes","volume":"2","author":"Soritz","year":"2022","journal-title":"Chemistry\u2013Methods"},{"key":"2025031307374170700_btaf060-B58","doi-asserted-by":"crossref","first-page":"188464","DOI":"10.1016\/j.bbcan.2020.188464","article-title":"Altered glycosylation in cancer: a promising target for biomarkers and therapeutics","volume":"1875","author":"Thomas","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2025031307374170700_btaf060-B59","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155621","article-title":"An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma","volume":"132","author":"Tian","year":"2022","journal-title":"J Clin Invest"},{"key":"2025031307374170700_btaf060-B60","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1021\/jasms.0c00021","article-title":"CIRFESS: an interactive resource for querying the set of theoretically detectable peptides for cell surface and extracellular enrichment proteomic studies","volume":"31","author":"Waas","year":"2020","journal-title":"J Am Soc Mass Spectrom"},{"key":"2025031307374170700_btaf060-B61","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2025031307374170700_btaf060-B62","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1158\/1538-7445.AM2023-1202","article-title":"Targeting cell adhesion molecule 1 (CADM1) with an antibody drug conjugate for the treatment of osteosarcoma","volume":"83","author":"Wang","year":"2023","journal-title":"Cancer Res"},{"key":"2025031307374170700_btaf060-B63","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1158\/1538-7445.AM2023-1202","article-title":"Abstract 1202: targeting cell adhesion molecule 1 (CADM1) with an antibody drug conjugate for the treatment of osteosarcoma","volume":"83","author":"Wang","year":"2023","journal-title":"Cancer Research"},{"key":"2025031307374170700_btaf060-B64","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13045-019-0758-x","article-title":"Target selection for CAR-T therapy","volume":"12","author":"Wei","year":"2019","journal-title":"J Hematol Oncol"},{"key":"2025031307374170700_btaf060-B66","doi-asserted-by":"crossref","first-page":"12696","DOI":"10.1038\/s41598-022-16940-7","article-title":"Exploiting gene dependency to inform drug development for multiple myeloma","volume":"12","author":"Went","year":"2022","journal-title":"Sci Rep"},{"key":"2025031307374170700_btaf060-B67","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2019-131056","article-title":"A BCMA and CD19 bispecific CAR-T for relapsed and refractory multiple myeloma","volume":"134","author":"Zhang","year":"2019","journal-title":"Blood"},{"key":"2025031307374170700_btaf060-B68","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btaf060\/61841829\/btaf060.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/41\/3\/btaf060\/61841829\/btaf060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/41\/3\/btaf060\/61841829\/btaf060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T03:38:24Z","timestamp":1741837104000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/doi\/10.1093\/bioinformatics\/btaf060\/8008580"}},"subtitle":[],"editor":[{"given":"Jonathan","family":"Wren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btaf060","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.06.04.597422","asserted-by":"object"}]},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,2,11]]},"article-number":"btaf060"}}